Marinus Pharmaceuticals signs collaboration deal worth up to $266M with Chinese biotech firm


The deal involving an anti-seizure medicine includes a $10 million upfront payment.

Previous St. Pete's Ark Investment to launch three mutual funds with BMO partnership
Next Caribou Coffee opens first standalone U.S. franchise location in Ohio